MSD is one of the world's leading research-based biopharmaceutical companies. For more than 125 years, we have been developing and providing medicines and vaccines that can improve the health of people and animals and enable them to live better lives.
MSD operates one of the world's largest and fastest growing clinical research programs in the field of immune-oncology. In Switzerland, we are currently conducting 31 clinical trials (as of 11/2020) in various types of cancer.
For more than 100 years, we have been researching and developing innovative vaccines to help prevent certain diseases in children, adolescents and adults.
Switzerland is one of more than fifty countries in which MSD conducts clinical research. The active substances discovered in the global MSD Research Laboratories are tested in Switzerland in all phases of clinical research.